07.01.14
Little Falls, N.J.-based Cantel Medical has completed the acquisition of PuriCore International Ltd., a wholly-owned subsidiary of PuriCore plc. With the deal, Cantel’s feet dig further into the global market for automated endoscope reprocessing and provides the company with additional resources and capabilities to execute on its broader international strategy. PuriCore International Ltd. will be renamed Cantel Medical (U.K.) Ltd. and will be reported as part of Cantel’s endoscopy segment, which is represented by Cantel’s subsidiary, Medivators.
PuriCore International Ltd. provides automated endoscope reprocessors, endoscope drying and storage cabinets, chemistry and consumables in addition to comprehensive maintenance and validation services in the United Kingdom. With an employee base of approximately 120 individuals, including a complete sales and service team and facilities in Stafford and Clevedon, England, the addition of PuriCore International provides Cantel Medical comprehensive coverage of the U.K. market.
“This acquisition is an exciting step in the execution of our international strategy,” said Jorgen Hansen, president of Medivators and chief operating officer of Cantel Medical. “The addition of the PuriCore endoscopy business to Medivators will meaningfully strengthen our offering in automated endoscope reprocessing while also enhancing our international capabilities and competitiveness. We are excited to welcome the entire PuriCore International workforce to the Cantel family, and we look forward to working together toward delivering infection prevention and control solutions to patients and customers worldwide.”
Medivators, which is headquartered in Minneapolis, Minn., focuses on hemodialysis, filtration and separation, medical device reprocessing and infection prevention.
PuriCore International Ltd. provides automated endoscope reprocessors, endoscope drying and storage cabinets, chemistry and consumables in addition to comprehensive maintenance and validation services in the United Kingdom. With an employee base of approximately 120 individuals, including a complete sales and service team and facilities in Stafford and Clevedon, England, the addition of PuriCore International provides Cantel Medical comprehensive coverage of the U.K. market.
“This acquisition is an exciting step in the execution of our international strategy,” said Jorgen Hansen, president of Medivators and chief operating officer of Cantel Medical. “The addition of the PuriCore endoscopy business to Medivators will meaningfully strengthen our offering in automated endoscope reprocessing while also enhancing our international capabilities and competitiveness. We are excited to welcome the entire PuriCore International workforce to the Cantel family, and we look forward to working together toward delivering infection prevention and control solutions to patients and customers worldwide.”
Medivators, which is headquartered in Minneapolis, Minn., focuses on hemodialysis, filtration and separation, medical device reprocessing and infection prevention.